Login with your work email address to view charts. No credit card required.
| Art Unit: | 1671 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1670 — Virology, Viral Immunology, And Viral Pathogens, Neurology, Receptors, Cytokines & Recombinant Hormones and Immunoassays and related devices |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 504 — Plant protecting and regulating compositions 250 — Radiant energy 514 — Drug, bio-affecting and body treating compositions 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| Phone: | (571) 272-0904 |
| Email: | bao-qun.li@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Biolgy |
| Service: | 26 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 78% over 325 cases |
|---|---|
| Difficulty: | Medium |
| Difficulty Percentile: | 48th
|
With Examiner Li, you have a 78% chance of getting an issued patent by 3 years after the first office action. Examiner Li is a medium examiner and in the 48th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Li, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Li's grant rate is higher than that of Art Unit 1671 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Li | 1.5 |
| Art Unit 1671 | 1.3 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.